Adult Tinea Capitis: a Clinical Entity in Increasing Frequency

  • Andrés Tirado-SánchezEmail author
  • Yessica Estrada-Caraveo
  • Mariana Saldaña
  • Alexandro Bonifaz
Fungal Infections of Skin and Subcutaneous Tissue (A Bonifaz and M Pereira, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Fungal Infections of Skin and Subcutaneous Tissue


Purpose of Review

This review summarizes the fungal literature currently available for adult tinea capitis (ATC), as well as providing data for clinical practice.

Recent Findings

Available studies in ATC are scarce; however, they provide essential information for treating ATC.


Treatment of TC is effective; however, it needs a minimum of 1 month to watch clinical efficacy. Systemic treatment is often needed to favor drug penetration to the deepest part of the hair follicle. The newest oral antifungal has higher efficacy rates than conventional therapy, as well as much shorter duration of treatment but at higher costs. We review the literature concerning ATC, including treatment schemes.


Adult tinea capitis Epidemiology Incidence Treatment 


Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    • Park SK, Park SW, Yun SK, Kim HU, Park J. Tinea capitis in adults: a 18-year retrospective, single-centre study in Korea. Mycoses. 2019;62:609–16. paper shows the most common clinical manifestations of tinea capitis in adults. CrossRefPubMedGoogle Scholar
  2. 2.
    Oh SH, Kim SH, Suh SB. Tinea capitis of adults in Taegu city for 11 years (1978~1988). Korean J Dermatol. 1989;27:666–79.Google Scholar
  3. 3.
    Aste N, Pau M, Biggio P. Tinea capitis in adults. Mycoses. 1996;39:299–301. Scholar
  4. 4.
    Mebazaa A, Oumari KE, Ghariani N, Mili AF, Belajouza C, Nouira R, et al. Tinea capitis in adults in Tunisia. Int J Dermatol. 2010;49:513–6. Scholar
  5. 5.
    El-Khalawany M, Shaaban D, Hassan H, et al. A multicenter clinicomycological study evaluating the spectrum of adult tinea capitis in Egypt. Acta Dermatovenerol Alp Pannonica Adriat. 2013;22:77–82. Scholar
  6. 6.
    • Lova-Navarro M, Gómez-Moyano E, Martínez Pilar L, Fernandez-Ballesteros MD, Godoy-Díaz DJ, Vera-Casaño A, et al. Tinea capitis in adults in southern Spain. A 17-year epidemiological study. Rev Iberoam Micol. 2016;33:110–3. paper shows the most common clinical manifestations of tinea capitis in adults. CrossRefPubMedGoogle Scholar
  7. 7.
    Devliotou-Panagliotidou D, Koussidou-Eremondi T, Chaidemenos GC, Theodoridou M, Minas A. Tinea capitis in adults during 1981-95 in northern Greece. Mycoses. 2001;44:398–400. Scholar
  8. 8.
    Cervetti O, Albini P, Arese V, Ibba F, Novarino M, Panzone M. Tinea capitis in adults. Adv Microbiol. 2014;4:12–4. Scholar
  9. 9.
    Duarte B, Galhardas C, Cabete J. Adult tinea capitis and tinea barbae in a tertiary Portuguese hospital: a 11-year audit. Mycoses. 2019. Scholar
  10. 10.
    Diop A, Ly F, Diagne F, Ndiaye MT, Seck B, Ndiaye M, et al. Epidemiological, clinical and etiological profile of tinea capitis in adult patients in Dakar, Senegal. Ann Dermatol Venereol. 2019;146:100–5. Scholar
  11. 11.
    Khosravi AR, Shokri H, Vahedi G. Factors in etiology and predisposition of adult tinea capitis and review of published literature. Mycopathologia. 2016;181:371–8. Scholar
  12. 12.
    •• Hay RJ. Tinea capitis: current status. Mycopathologia. 2017;182:87–93. paper gives important strategies for treating tinea capitis. CrossRefPubMedGoogle Scholar
  13. 13.
    • Rebollo N, López-Barcenas AP, Arenas R. Tinea apitis. Actas Dermosifiliogr. 2008;99:91–100. paper offers an excellent overview of the disease. CrossRefPubMedGoogle Scholar
  14. 14.
    Bennassar A, Grimalt R. Management of tinea capitis in childhood. Clin Cosmet Investig Dermatol. 2010;3:89–98.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Beardsley J, Denning DW, Chau NV, Yen NT, Crump JA, Day JN. Estimating the burden of fungal disease in Vietnam. Mycoses. 2015;58:101–6. Scholar
  16. 16.
    Nenoff P, Krüger C, Ginter-Hanselmayer G, Tietz HJ. Mycology - an update. Part 1: dermatomycoses: causative agents, epidemiology, and pathogenesis. J Dtsch Dermatol Ges. 2014;12:188–209. Scholar
  17. 17.
    Farag AGA, Hammam MA, Ibrahem RA, Mahfouz RZ, Elnaidany NF, Qutubuddin M, et al. Epidemiology of dermatophyte infections among school children in Menoufia Governorate, Egypt. Mycoses. 2018;61:321–5. Scholar
  18. 18.
    Aly R. Ecology, epidemiology and diagnosis of tinea capitis. Pediatr Infect Dis J. 1999;18:180–5. Scholar
  19. 19.
    Cafarchia C, Romito D, Capelli G, Guillot J, Otranto D. Isolation of Microsporum canis from the hair coat of pet dogs and cats belonging to owners diagnosed with M. canis tinea corporis. Vet Dermatol. 2006;17:327–31. Scholar
  20. 20.
    Lee JY, Hsu ML. Tinea capitis in adults in Southern Taiwan. Int J Dermatol. 1991;30:572–5. Scholar
  21. 21.
    Silverberg NB, Weinberg JM, DeLeo VA. Tinea capitis: focus on African American women. J Am Acad Dermatol. 2002;46:S120–4. Scholar
  22. 22.
    Toksöz L, Güzel AB, Ilkit M, Akar T, Saraçlı MA. Scalp dermatophyte carriage in pregnant, pre-, and postmenopausal women: a comparative study using the hairbrush and cytobrush methods of sample collection. Mycopathologia. 2011;171:339–44. Scholar
  23. 23.
    Chen W, Yang CC, Todorova A, Al Khuzaei S, Chiu HC, Worret WI, et al. Hair loss in elderly women. Eur J Dermatol. 2010;20:145–51. Scholar
  24. 24.
    Yamada N, Wakumoto K, Yamamoto O. Scanning electron microscopic observation on the parasitic form of the fungi in the horny layer in dermatophytosis. Med Mycol J. 2012;53:117–21. Scholar
  25. 25.
    Kaufman G, Horwitz BA, Duek L, Ullman Y, Berdicevsky I. Infection stages of the dermatophyte pathogen Trichophyton: microscopic characterization and proteolytic enzymes. Med Mycol. 2007;45:149–55. Scholar
  26. 26.
    Terragni L, Lasagni A, Oriani A. Tinea capitis in adults. Mycoses. 1989;32:482–6.CrossRefGoogle Scholar
  27. 27.
    Chen M, Xu Y, Hong N, Yang Y, Lei W, Du L, et al. Epidemiology of fungal infections in China. Front Med. 2018;12:58–75. Scholar
  28. 28.
    Chokoeva AA, Zisova L, Sotiriou E, Miteva-Katrandzhieva T. Tinea capitis: a retrospective epidemiological comparative study. Wien Med Wochenschr. 2017;167:51–7. Scholar
  29. 29.
    Vena GA, Chieco P, Posa F, Garofalo A, Bosco A, Cassano N. Epidemiology of dermatophytoses: retrospective analysis from 2005 to 2010 and comparison with previous data from 1975. New Microbiol. 2012;35:207–13.PubMedGoogle Scholar
  30. 30.
    Farokhipor S, Ghiasian SA, Nazeri H, Kord M, Didehdar M. Characterizing the clinical isolates of dermatophytes in Hamadan city, central west of Iran, using PCR-RLFP method. J Mycol Med. 2018;28:101–5. Scholar
  31. 31.
    Allahdadi M, Hajihossein R, Kord M, Rahmati E, Amanloo S, Didehdar M. Molecular characterization and antifungal susceptibility profile of dermatophytes isolated from scalp dermatophyte carriage in primary school children in Arak city, center of Iran. J Mycol Med. 2019;29:19–23. Scholar
  32. 32.
    Deng S, Zhou Z, de Hoog GS, Wang X, Abliz P, Sun J, et al. Evaluation of two molecular techniques for rapid detection of the main dermatophytic agents of tinea capitis. Br J Dermatol. 2015;173:1494–500. Scholar
  33. 33.
    Bourezane Y, Bourezane Y. Analysis of trichoscopic signs observed in 24 patients presenting tinea capitis: hypotheses based on physiopathology and proposed new classification. Ann Dermatol Venereol. 2017;144:490–6. Scholar
  34. 34.
    Lacarrubba F, Micali G, Tosti A. Scalp dermoscopy or thichoscopy. Curr Probl Dermatol. 2015;47:21–32. Scholar
  35. 35.
    Daroach M, Hanumanthu V, Kumaran MS. Utility of trichoscopy in tinea capitis. Postgrad Med J. 2019;95:173. Scholar
  36. 36.
    Lekkas D, Ioannides D, Apalla Z, Lallas A, Lazaridou E, Sotiriou E. Dermoscopy for discriminating between Trichophyton and Microsporum infections in tinea capitis. J Eur Acad Dermatol Venereol. 2018;32:e234–5. Scholar
  37. 37.
    Campos S, Brasileiro A, Galhardas C, Apetato M, Cabete J, Serrão V, et al. Follow-up of tinea capitis with trichoscopy: a prospective clinical study. J Eur Acad Dermatol Venereol. 2017;31:e478–80. Scholar
  38. 38.
    Arrazola-Guerrero J, Isa-Isa R, Torres-Guerrero E, Arenas R. Tinea capitis. Dermoscopic findings in 37 patients. Rev Iberoam Micol. 2015;32:242–6. Scholar
  39. 39.
    Auchus IC, Ward KM, Brodell RT, Brents MJ, Jackson JD. Tinea capitis in adults. Dermatol Online J. 2016;22.Google Scholar
  40. 40.
    Trovato MJ, Schwartz RA, Janniger CK. Tinea capitis: current concepts in clinical practice. Cutis. 2006;77:93–9.PubMedGoogle Scholar
  41. 41.
    Wigger-Alberti W, Elsner P. Fluorescence with Wood’s light. Current applications in dermatologic diagnosis, therapy follow-up and prevention. Hautarzt. 1997;48:523–7.CrossRefGoogle Scholar
  42. 42.
    Bhanusali D, Coley M, Silverberg JI, Alexis A, Silverberg NB. Treatment outcomes for tinea capitis in skin of color population. J Drugs Dermatol. 2012;11:852–6.PubMedGoogle Scholar
  43. 43.
    • Bar J, Samuelov L, Sprecher E, Mashiah J. Griseofulvin vs terbinafine for paediatric tinea capitis: when and for how long. Mycoses. 2019. important review of the main therapeutic options for adult tinea capitis. CrossRefGoogle Scholar
  44. 44.
    Tey HL, Tan AS, Chan YC. Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis. J Am Acad Dermatol. 2011;64:663–70. Scholar
  45. 45.
    •• Chen X, Jiang X, Yang M, Bennett C, González U, Lin X, et al. Systemic antifungal therapy for tinea capitis in children: an abridged Cochrane review. J Am Acad Dermatol. 2017;76:368–74. paper that summarizes the clinical trials available for tinea capitis. CrossRefPubMedGoogle Scholar
  46. 46.
    Gupta AK, Adam P, Hofstader SL, Lynde CW, Taborda P, Taborda V, et al. Intermittent short duration therapy with fluconazole is effective for tinea capitis. Br J Dermatol. 1999;141:304–6. Scholar
  47. 47.
    Nyawalo JO, Bwire M. Single dose and intermittent griseofulvin regimens in the treatment of tinea capitis in Kenya. Mycoses. 1988;31:229–34. Scholar
  48. 48.
    McClellan KJ, Wiseman LR, Markham A. Terbinafine. An update of its use in superficial mycoses. Drugs. 1999;58:179–202. Scholar
  49. 49.
    Danielli LJ, Lopes W, Vainstein MH, Fuentefria AM, Apel MA. Biofilm formation by Microsporum canis. Clin Microbiol Infect. 2017;23:941–2. Scholar
  50. 50.
    Ginter-Hanselmayer G, Smolle J, Gupta A. Itraconazole in the treatment of tinea capitis caused by Microsporum canis: experience in a large cohort. Pediatr Dermatol. 2004;21:499–502. Scholar
  51. 51.
    Kovacs SO, Hruza LL. Superficial fungal infections. Getting rid of lesions that don’t want to go away. Postgrad Med. 1995;98:61–2 68–9, 73–5.CrossRefGoogle Scholar
  52. 52.
    Degreef HJ, DeDoncker PR. Current therapy of dermatophytosis. J Am Acad Dermatol. 1994;31:S25–30. Scholar
  53. 53.
    Ferguson L, Fuller LC. Spectrum and burden of dermatophytes in children. J Inf Secur. 2017;74:S54–60. Scholar
  54. 54.
    Bournerias I, De Chauvin MF, Datry A, Chambrette I, Carriere J, Devidas A, et al. Unusual Microsporum canis infections in adult HIV patients. J Am Acad Dermatol. 1996;35:808–10. Scholar
  55. 55.
    Lo AC, Lui SL, Lo WK, Chan DT, Cheng IK. The interaction of terbinafine and cyclosporine a in renal transplant patients. Br J Clin Pharmacol. 1997;43:340–1.PubMedGoogle Scholar
  56. 56.
    Güleç AT, Demirbilek M, Seçkin D, Can F, Saray Y, Sarifakioglu E, et al. Superficial fungal infections in 102 renal transplant recipients: a case-control study. J Am Acad Dermatol. 2003;49:187–92. Scholar
  57. 57.
    Mikaeili A, Kavoussi H, Hashemian AH, Shabandoost Gheshtemi M, Kavoussi R. Clinico-mycological profile of tinea capitis and its comparative response to griseofulvin versus terbinafine. Curr Med Mycol. 2019;5:15–20. Scholar
  58. 58.
    Gupta AK, Mays RR, Versteeg SG, Piraccini BM, Shear NH, Piguet V, et al. Tinea capitis in children: a systematic review of management. J Eur Acad Dermatol Venereol. 2018;32:2264–74. Scholar
  59. 59.
    Frymus T, Gruffydd-Jones T, Pennisi MG, Addie D, Belák S, Boucraut-Baralon C, et al. Dermatophytosis in cats: ABCD guidelines on prevention and management. J Feline Med Surg. 2013;15:598–604. Scholar
  60. 60.
    Kelati A, Meziane M, Soughi M, Mernissi F. Erythema nodosum due to tinea. Arch Pediatr. 2016;23:727–30. Scholar
  61. 61.
    Romano C, Gaviria EM, Feci L, Fimiani M. Erythema nodosum complicating kerion of the scalp caused by Trichophyton mentagrophytes. J Eur Acad Dermatol Venereol. 2016;30:357–9. Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Andrés Tirado-Sánchez
    • 1
    • 2
    Email author
  • Yessica Estrada-Caraveo
    • 1
  • Mariana Saldaña
    • 1
  • Alexandro Bonifaz
    • 1
  1. 1.Dermatology DepartmentHospital General de MéxicoMexico CityMexico
  2. 2.Internal Medicine DepartmentInstituto Mexicano del Seguro SocialCiudad de MéxicoMexico

Personalised recommendations